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Hypertensive Hypertrophic Cardiomyopathy or Hypertrophic 
Cardiomyopathy With Hypertension?: A Study of 78 Patients 
ROGER KARAM, MD, HARRY M. LEVER, MD, FACC, BERNADINE P. HEALY, MD, FACC 
Cleveland, Ohio 
Hypertensive hypertrophic cardiomyopathy may be a dis- 
tinctive cardiac condition resulting from hypertension. Al- 
ternatively, this disease may represent the coincidence of a 
common disease, hypertension, with a relatively rare car- 
diomyopathy. A consecutive series of patients with hyper- 
trophic cardiomyopathy and hypertension were studied and 
compared with age- and gender-matched patients with 
cardiomyopathy alone. 
Thirty-nine patients were identified as having hyperten- 
sion; they ranged in age from 31 to 84 years (average 60 -t 
13); 82% were SO years old; 18 (46%) were women. When 
these patients were compared with the age-matched group 
with hypertrophic cardiomyopathy alone, there were no 
clinical or electrocardiographic differences between the two 
groups. By echocardiography, the hypertensive and nonhy- 
pertensive groups had a similar incidence of systolic ante- 
rior motion (77 versus 64%, respectively), mitral annular 
In 1957, when Brock (1) described in an elderly patient 
severe hypertrophy of the left ventricle that produced a left 
ventricular outflow tract obstruction simulating severe 
symptomatic aortic stenosis, he concluded that this disease 
was secondary to severe hypertension. In 1959 he (2) sug- 
gested that hypertension might not be the “chief factor” 
when he reported that in a new series of six patients with 
myocardial hypertrophy, only two had a history of hyper- 
tension, In 1958, Teare (3) described severe left ventricular 
hypertrophy that simulated a tumor in the heart; the patients 
were young, and none had hypertension. Since that time, 
numerous patients with hypertrophic cardiomyopathy have 
been studied. The heart in this condition is now character- 
ized by a hypertrophied, nondilated left ventricle with de- 
creased compliance and impaired diastolic relaxation. Fea- 
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calcification (31 versus 31%), septal thickness >20 mm (56 
versus 46%) and outflow tract gradient >20 mm (59 versus 
67%). A posterior wall thickness >13 mm was more 
frequent in the hypertensive group (54%) compared with 
the nonhypertensive group (31%) (p = 0.02). 
The findings show that hypertrophic cardiomyopathy 
with associated hypertension is a disease of the elderly. But, 
with the exception of thicker walls, the clinical and echo- 
cardiographic features of the patients with hypertension 
were indistinguishable from those of the age-matched and, 
hence, elderly group of patients with cardiomyopathy with- 
out hypertension. These findings suggest that hypertension 
may make hypertrophy worse, but that it is not the primary 
cause of the cardiomyopathy. Thus, the condition might be 
better termed “hypertrophic cardiomyopathy with hyper- 
tension.” 
(J Am Co11 Cardiol1989;13:5804) 
tures of this disease may also (but do not necessarily) include 
asymmetric hypertrophy, a histologic pattern of myocardial 
fiber disarray, a left ventricular outflow tract gradient and 
systolic anterior motion of the mitral valve. 
Thus, the definition of this condition has become simply 
nondilated hypertrophy with abnormalities of systolic and 
diastolic function of no known cause. Regardless of its 
origin, however, hypertrophy can be associated with these 
structural and functional abnormalities. Consequently, other 
causes of hypertrophy-e.g., aortic stenosis, hypertension 
or (rarely) myocardial infiltrative diseases such as amyloid 
(4) or glycogen storage disease @)-are excluded in making 
this diagnosis. 
One potentially coexisting condition continues to be 
problematic in assessing whether hypertrophic cardiomyop- 
athy is “idiopathic” or “secondary;” namely, mild to mod- 
erate systemic hypertension. Some investigators (6-8) in- 
clude patients with hypertension in studies of hypertrophic 
cardiomyopathy, whereas others (9-11) do so only some- 
times. What is not clear from these diverse approaches is 
whether hypertrophic cardiomyopathy with hypertension is 
a distinct pathophysiologic subset of hypertrophic cardiomy- 
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opathy in which blood pressure elevation is likely causal or 
whether systemic hypertension is an associated, but at most 
aggravating, condition superimposed on an underlying car- 
diomyopathy. 
To address this issue, we studied 39 consecutive patients 
with the diagnosis of hypertrophic cardiomyopathy who also 
had systemic hypertension of mild to moderate severity and 
compared them with an age- and gender-matched group of 
patients with hypertrophic cardiomyopathy who were nor- 
motensive and had no history of hypertension. The findings 
show that hypertrophic cardiomyopathy is similar in all 
respects in patients with and without systemic hypertension, 
and suggest that hypertension may be a cofactor but is likely 
not a cause of their cardiac disease. 
Methods 
Patients studied. We reviewed the records of the echo- 
cardiographic laboratory at The Cleveland Clinic Founda- 
tion between January 1986 and December 1987 for the 
diagnosis of hypertrophic cardiomyopathy. The only criteria 
for exclusion were a poor quality echocardiogram and the 
presence of primary valvular disease or end-stage renal 
disease. All patients had an echocardiogram because of 
some clinical suspicion of cardiac disease. 
The diagnosis was based on accepted criteria, combining 
echocardiographic, Doppler and cardiac catheterization 
data. In addition to left ventricular hypertrophy (septum 2 15 
mm with a normal to small-sized cavity), a combination of 
the following variables was present: systolic anterior motion 
of mitral valve at rest or with provocation; presence of a 
gradient in the left ventricular outflow tract by Doppler 
ultrasound or cardiac catheterization, at rest or with provo- 
cation; and asymmetry of the interventricular septum. The 
clinical charts and echocardiographic studies were reviewed 
separately and at different times for all patients. 
After reviewing the clinical data, we identified those 
patients (Group 1) who had hypertrophic cardiomyopathy 
and arterial hypertension. We then selected from our com- 
puter data bank a second comparison group (Group 2) from 
the remaining 74 patients with hypertrophic cardiomyopathy 
alone. Thirty-nine of the 74 patients were chosen at random 
to provide age- and gender-match with patients in Group I. 
Clinical data. Data were collected from clinical records. 
Functional class was based on the New York Heart Associ- 
ation classification (I to IV). Hypertension was defined as 
blood pressure >140/90 mm Hg in the young and >160/95 
mm Hg in the elderly (>65 years), as recommended by the 
Framingham study (12). The electrocardiograms (ECG) were 
reviewed for the following: 1) cardiac rhythm; 2) left ven- 
tricular hypertrophy, as defined by S wave in lead V, + R 
wave in lead V, or S wave in lead V, + R wave in lead V, 
~-35 mm, or R wave in lead aVL 2 11 mm or combinations; 
3) presence of a Q wave in the anteroseptal or lateral 
precordial leads; and 4) intraventricular conduction abnor- 
malities. 
Echocardiographic data. Echocardiographic studies were 
performed with use of either a Hewlett-Packard instrument 
with a 2.5/l .9 MHz transducer, an Aloka 880 instrument with 
a 3.512.0 MHz transducer or an Irex Meridian instrument 
with a 3.512.0 MHz transducer. All images were recorded on 
0.5 in. (1.27 cm) VHS video tape recorders. Tapes were 
reviewed on a Panasonic editing controller system with a 
Panasonic AG-6500 video recorder. Each echocardiographic 
study was reviewed by three investigators without knowl- 
edge of patient age or clinical data. Only those echocardio- 
grams that were technically inadequate for detailed analysis 
were discarded from the study. The following variables were 
identified as features for analysis during formal prospective 
evaluation of the echocardiograms: 
1) Symmetry or asymmetry was determined by using both 
M-made und two-dimensional echocardiography. Measure- 
ments of wall thickness that led to the final determination 
were obtained from the M-mode recording. Wall thickness 
measurements were made according to the American Soci- 
ety of Echocardiography (ASE) recommendations for mea- 
surements of the septum and posterior wall of the left 
ventricle (13). 
2) Systolic anterior motion of the mitral valve was recog- 
nized with M-mode and two-dimensional echocardiography 
when a displacement of the anterior or posterior leaflets, or 
both, toward the septum in systole was observed, with or 
without amyl nitrite provocation. 
3) Mitral annular calcification was looked for and de- 
scribed as an increased echo density of the anulus in the 
parasternal long-axis, short-axis and four-chamber views. 
4) Left ventricular outjow gradient was measured either 
by continuous wave Doppler echocardiography or at the 
time of cardiac catheterization. The Doppler measurements 
were made in m/s and then converted to mm Hg with use of 
the simplified Bernoulli equation p = 4V”. where p = 
pressure gradient and V = 4. 
5) Cardiac shape determination included an assessment 
of overall cavity contour and septal curvature as determined 
from apical four-chamber and parasternal long-axis views, 
6) Right ventricular free wall prominence was determined 
in the apical four-chamber view, and described when the 
right ventricular free wall appeared increased in thickness 
and there was muscular obliteration of the moderator band 
and apex leading to loss of the normal crescent shape of the 
cavity. To help substantiate right ventricular free wall prom- 
inence, the parasternal short- and long-axis views were also 
used whenever they were well visualized. 
Statistical analysis. A Student’s t test was used to com- 
pare mean values between groups. Associations for contin- 
gency table data were tested using the chi-square statistic 
when appropriate. For tables with small expected cell fre- 
quencies. exact tests (Fisher’s exact or an exact chi-square) 
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Table 1. Clinical Data in 78 Age- and Gender-Matched Patients 
Patients 
Hypertensive Normotensive 
(n = 39) (n = 39) 
Gender 
Male 21 21 
Female 18 18 
Mean age (yr) 60? 13 60 r 14 
r SD 
Dyspnea 35 (90%) 21 (69%)* 
Palpitation 30 (77%) 24 (62%) 
Angina 20 (51%) 21 (54%) 
Syncope 10 (26%) 7 (18%) 
Murmur (grade) 
0 3 7 
1 3 1 
2 to 3 31 30 
>4 2 1 
NYHA class 
I 3 6 
II 18 23 
III 17 9 
IV 1 1 
ECG 
LVH 30 (77%) 25 (64%) 
AF 7 (18%) 7 (18%) 
LBBB 4 (10%) 3 (8%) 
RBBB 1(3%) 7 (17%) 
Q-Ant-Sep 15 (39%) 18 (46%) 
Coronary angiogram 16 24 
Coronary obstruction ~30% 5 (31%) 8 (33%) 
*p = 0.02. AF = atrial fibrillation; ECG = electrocardiography; LBBB = 
left bundle branch block; LVH = left ventricular hypertrophy; NYHA class = 
New York Heart Association functional class; Q-Ant-Sep = Q wave in 
anteroseptal leads; RBBB = right bundle branch block. 
were used; p values so.01 were considered to be statistically 
significant. 
Results 
Clinical findings (Table 1). One hundred thirteen patients 
were evaluated at the Cleveland Clinic between 1986 and 
1987 and diagnosed as having hypertrophic cardiomyopathy. 
Of these, 39 patients with both hypertrophic cardiomyopa- 
thy and systemic hypertension (Group 1) were identified. 
They ranged in age from 31 to 84 years (mean + SD 60 ? 13); 
82% of them were >50 years old. The remaining 74 patients 
with the diagnosis of hypertrophic cardiomyopathy without 
hypertension were significantly younger (49.7 + 18 years; 
p < 0.001). Eighteen (46%) of the 39 Group 1 patients were 
women. The duration of hypertension ranged from 1 to 40 
years (mean 11 + 9) in the 23 patients in whom it was known. 
These 23 patients had an average blood pressure of 188.4 -+ 
27 mm Hg systolic and 99 ? 21 mm Hg diastolic. All patients 
had their blood pressure controlled with medications. 
Comparison group. By comparison, Group 2 consisted of 
39 of the 74 patients with hypertrophic cardiomyopathy 
without hypertension, matched for age and gender with 
Group 1 patients. Cardiac symptoms, murmurs, functional 
class and ECG abnormalities were virtually identical in the 
two groups. 
Echocardiographic findings (Table 2). All 39 patients with 
hypertrophic cardiomyopathy and hypertension (Group 1) 
had septal hypertrophy 215 mm. Septal thickness was 15 to 
20 mm in 17 patients (44%) and >20 mm in 22 (55%); the 
mean thickness was 20 + 3.7 mm. The posterior free wall of 
the left ventricle was >13 mm in 21 patients (54%) (mean 14 
? 2.5). The septum to free-wall ratio was > 1.3 in 24 patients 
(62%). Systolic anterior motion of the mitral valve was 
present in 17 patients (44%) at rest and in 13 (33%) after 
provocation with amyl nitrite. 
Fractional shortening was >30% in 38 patients (97%) 
(mean 46 ? 8.6%). End-diastolic diameter was ~55 mm in 33 
patients (85%) (mean 43 2 6.9 mm); end-systolic diameter 
was ~35 mm in 37 patients (95%) (mean 24 + 6.4). The left 
atria1 dimension was >40 mm in 28 patients (72%) (mean 43 
+ 6.9) and the aortic root dimension was ~40 mm in 38 
patients (97%) (mean 35 ? 4.2). Mitral calcification was 
present in 12 patients (31%), of whom 1 was 53 years old and 
the remaining 11 were >60 years old. The left ventricular 
outflow gradient was >20 mm Hg in 23 patients (59%) (mean 
80 r 34). 
In the left ventricle, reversal of the normal septal curva- 
ture was seen in seven patients (18%); in six of them, the 
right ventricular wall was also prominent, suggesting right 
ventricular hypertrophy. A normal contoured ovoid ventri- 
cle was present in the remaining 32 patients (82%), and 18 
(46%) of them also had a proximal septal bulge. There was 
no correlation between left ventricular shape and levels of 
blood pressure in Group 1. 
Echocardiographic findings in Group 2 were similar to 
those in Group 1, with one exception. The posterior wall 
thickness was >13 mm in 12 patients (31%) in Group 2 and 
the mean value in Group 2 of 13 t 2.6 mm was significantly 
less than that of Group 1 patients with hypertension. In 
Group 2, all patients had a septal wall thickness >15 mm 
(mean 20 ? 4.7); and 18 (46%) had a septal wall thickness 
>20 mm. 
There were no significant differences between the two 
groups in systolic anterior motion of the mitral valve at rest 
and after provocation, fractional shortening, end-diastolic 
diameter, end-systolic diameter, left atria1 dimension and 
aortic root dimension. The left ventricular outflow gradient 
was >20 mm Hg in 26 patients (67%) (mean 85 +- 45). 
Reversed septal curvature was observed in 12 patients 
(31%), and 11 of them also had right ventricular wall prom- 
inence. An ovoid left ventricle was present in 27 patients 
(69%) of whom 13 (33%) had a proximal septal bulge. Mitral 
calcification was present in 12 patients (31%), all of them 
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Table 2. Echocardiographic Data in 78 Patients 
Patients 
Hypertensive Normotensive 
(n = 39) (n = 39) 
Sept (mm) 
<20 I7 (44%) 21 (54%) 
22s 17 (44%) 12 (31%) 
>25 5 (12%) 6 (15%) 
jc + SD 20 k 3.7 20 ? 4.7 
Post wall (mm) 
<IO 1 (3%) I (3%) 
IO to 13 I7 (43%) 26 (66%) 
>I3 21 (54%) I2 (31%)* 
jc t SD 14 + 2.5 13 ? 2.6 
SeptiPost wall 
ct.3 I5 (38%) 7 (18R)t 
>I.3 24 (62%) 32 (82%) 
Gradient (mm Hg) 
<20 I6 (41%) I3 (33%) 
20 to so 4 (IO%) 6 (15%) 
>50 I9 (49%) 20 (52%) 
ic + SD 80 r 34 85 + 45 
SAM 
rest I7 (44%) 16 (41%) 
after provocation I3 (33%) 10 (26%) 
Ovoid left ventricle 32 (82%) 27 (69%) 
Proximal septal bulge 18 (46%) I3 (33%) 
Reversed septum 7 (18%) I2 (31%) 
RV Wall prominence IO (26%) 15 (38%) 
Reversed septum and RV 6 (86%) I I (92%) 
wall prominence 
Mitral talc I2 (31%) I2 (31%) 
*p = 0.02; tp = 0.03. AR = aortic root dimension; EDD = end-diastolic 
diameter; ESD = end-systolic diameter; FS = fractional shortening; LA = left 
atrial dimension; Mitral talc = annular calcification; Post wall = posterior 
wall; SAM = systolic anterior motion of the mitral valve; Sept = septum. 
>60 years old. None of these findings differed from those 
found in Group 1 patients with hypertension. 
Discussion 
Role of hypertension in hypertrophic cardiomyopathy. 
Hypertension of mild to moderate degree sometimes occurs 
in patients with hypertrophic cardiomyopathy, but predom- 
inantly among the elderly. Our 39 hypertensive patients in 
Group 1 had a mean age of 60 years, and were significantly 
older than the 74 patients with hypertrophic cardiomyopathy 
without hypertension studied during the same time period. 
Comparison of Group 1 patients with the 39 age- and 
gender-matched patients with hypertrophic cardiomyopathy 
without hypertension, however, revealed no differences in 
symptoms, functional class, ECG changes, left ventricular 
outflow tract obstruction or most echocardiographic find- 
ings, including asymmetric hypertrophy. One notable excep- 
tion was that those with hypertension were apt to have a 
thicker posterior left ventricular wall. These findings suggest 
that the cardiac disease of patients who present with hyper- 
trophic cardiomyopathy with blood pressure elevation is 
indistinguishable from idiopathic hypertrophic cardiomyop- 
athy and not a distinct condition necessarily related to 
hypertension. Of particular importance, the patients with 
hypertension had the same diverse spectrum of disease 
forms (including symmetry and asymmetry, obstruction and 
nonobstruction and systolic anterior motion and normal 
mitral motion) as did those without hypertension. 
Top01 et al. (14) recently described severe concentric 
hypertrophy and heart failure in 21 patients 259 years of age 
with mild to moderate hypertension. Although they labeled 
the syndrome “hypertensive hypertrophic cardiomyopathy” 
to distinguish it from the “classic” hypertrophic cardiomy- 
opathy associated with asymmetric hypertrophy, the hyper- 
trophy was more severe than that ordinarily seen with 
hypertension, and they viewed the disease as part of the 
spectrum of hypertrophic cardiomyopathy. Our studies 
further suggest that excluding these patients by attributing 
their disease to high blood pressure may obsure the fact that 
we do not fully understand the cause of this disease. 
A relevant issue, raised by Tarazi and Levy (IS), is that 
the severity of hypertrophy often cannot be related to the 
severity or duration of hypertension. They suggested that 
some patients may have a predisposed myocardial sensitiv- 
ity to the development of hypertrophy in the setting of 
hypertension. Other investigators (16) have shown clearly 
that only a minority of patients with chronic mild to moder- 
ate hypertension develop clinically detectable left ventricu- 
lar hypertrophy. Disease prevalence data also indicate that 
systemic hypertension, a common disorder, does not pre- 
dictably lead to cardiomyopathy, a relatively rare condition. 
Hypertension (defined as a blood pressure > 140190 mm Hg) 
is present in approximately two-thirds of patients 265 years 
old and in one-third of the general population (17). 
H!:pertension may, however, be a cofactor, if not neces- 
sarily the cause of cardiomyopathic remodeling. In a heart 
with hypertrophic cardiomyopathy it might be expected 
to aggravate the condition by leading to an additional in- 
crease in myocardial mass. This is suggested by our study, 
in which hypertensive patients had more free wall hypertro- 
phy than did normotensive patients. In the patients with 
hypertension, however, there was no evidence that their 
clinical condition was worsened by their elevated blood 
pressure. 
Diagnostic implications. There are inconsistencies in how 
hypertension is regarded in the setting of hypertrophic 
cardiomyopathy. A history of hypertension has been used as 
an exclusion criterion when making the diagnosis of idio- 
pathic hypertrophic cardiomyopathy (9,lO) but there are 
many exceptions. In 1966, in one of the earliest reports of 
hypertrophic cardiomyopathy in the elderly, Sanders et al. 
(18) described this condition in two sisters. one with a blood 
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pressure of 190/100 mm Hg. In an autopsy study (7) of 
idiopathic hypertrophic cardiomyopathy in which all pa- 
tients had asymmetric hypertrophy and myocardial fiber 
disarray in the septum, one-third of them had a prior history 
of hypertension. In a recent study (8) of the frequency and 
significance of mitral annular calcification in hypertrophic 
cardiomyopathy, 10 of 16 patients 265 years old were 
hypertensive. Some investigators (11) exclude patients with 
systemic hypertension in their studies, unless they believe 
that the degree of hypertrophy is greater than would be 
expected in patients with hypertension alone. The latter is a 
highly subjective determination. Thus, although some ex- 
clude patients from the diagnosis of hypertrophic cardiomy- 
opathy if there is a history of hypertension, exclusion criteria 
are quite variable and create inconsistencies in our clinical 
diagnosis and approach to patients with either hypertension 
or cardiomyopathy. 
Conclusions. Hypertrophic cardiomyopathy with hyper- 
tension appears to be part of the diverse spectrum of 
idiopathic hypertrophic cardiomyopathy. Although hyper- 
tension with hypertrophic cardiomyopathy is more apt to 
occur in the elderly, the differences are minimal between 
hypertrophic cardiomyopathy in patients with and those 
without hypertension when matched for age. Thus, in both 
young and old patients, and in those with or without hyper- 
tension, hypertrophic cardiomyopathy must be explained by 
factors other than blood pressure. To label this condition 
“secondary” when hypertension is present at best creates 
the satisfaction of defining etiology, but at worst obscures 
the real uncertainties as to the cause and relation to other 
forms of the disease. Thus, the condition (or conditions) 
might be better termed hypertrophic cardiomyopathy with 
hypertension, rather than hypertensive hypertrophic cardio- 
myopathy. 
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